Peter Attia· MD
when we talk about such a prevalent phenomenon like steatosis um we have to maintain practicality so the vast majority is going to be an Imaging based modality rather than something like a biopsy
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
when we talk about such a prevalent phenomenon like steatosis um we have to maintain practicality so the vast majority is going to be an Imaging based modality rather than something like a biopsy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
a plain old ultrasound that someone gets is generally not detecting steatosis at levels under 30% so an important take home is you know a negative ultrasound does not mean that you don't have hepatic steatosis